Piper Sandler Trims Aptose Biosciences (NASDAQ:APTO) Target Price to $5.00
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its target price cut by Piper Sandler from $12.00 to $5.00 in a research note released on Thursday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Several other research analysts have also commented on the stock. StockNews.com raised shares of Aptose […]
More Stories
EagleClaw Capital Managment LLC Sells 335 Shares of Franco-Nevada Co. (NYSE:FNV)
EagleClaw Capital Managment LLC cut its stake in Franco-Nevada Co. (NYSE:FNV – Free Report) (TSE:FNV) by 0.7% in the third...
EagleClaw Capital Managment LLC Sells 75 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)
EagleClaw Capital Managment LLC reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.2% in the...
Sachetta LLC Reduces Position in iShares Core S&P 500 ETF (NYSEARCA:IVV)
Sachetta LLC reduced its position in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 1.7% in...
5 Undecided House Races Will Determine Size of GOP’s Narrow Majority
By Stacy Robinson Although two weeks have passed since election night, several races for the U.S. House of Representatives have...
EagleClaw Capital Managment LLC Purchases 275 Shares of Madison Square Garden Sports Corp. (NYSE:MSGS)
EagleClaw Capital Managment LLC increased its holdings in Madison Square Garden Sports Corp. (NYSE:MSGS – Free Report) by 2.0% during...
Artificial Intelligence Technology Solutions (AITX) Launches SARA™, a Groundbreaking AI-driven Security Solution
Artificial Intelligence Technology Solutions Inc. (OTCMKTS:AITX) has recently unveiled SARA™ (Speaking Autonomous Responsive Agent), a cutting-edge AI-driven software created by...